QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ARGX

QT80argenx SE
NASDAQ·Healthcare·Biotechnology·NL
Latest market price
877.72
-14.54-1.63%
OverviewShort InterestFilings
ARGXQT80argenx SE·NASDAQ
OverviewShort InterestFilings
877.72-1.63%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89RPRX-1.38%$52.96
Snapshot
Index-P/E48.69EPS (ttm)
24.75
Insider Own-
Shs Outstand62.19M
Perf Week-2.36%
Market Cap55.38BForward P/E24.25EPS next Y36.19Insider Trans-Shs Float-Perf Month10.02%
Enterprise Value51.93BPEG0.07EPS next Q-Inst Own-Short Float-Perf Quarter28.23%
Income1.14BP/S16.39EPS this Y7.59%Inst Trans-Short Ratio-Perf Half Y3.09%
Sales3.38BP/B7.50EPS next Y35.91%ROA13.00%Short Interest-Perf YTD4.37%
Book/sh117.75P/C73.42EPS next 5Y22.29%ROE16.82%52W High934.64 -6.09%Perf Year62.33%
Cash/sh71.39P/FCF74.55EPS past 3/5Y-ROIC11.74%52W Low510.07 72.08%Perf 3Y-
Dividend Est.-EV/EBITDA48.98Sales past 3/5Y116.19% 151.83%Gross Margin89.00%Volatility1.88% 1.92%Perf 5Y-
Dividend TTM-EV/Sales15.37EPS Y/Y TTM17.76%Oper. Margin25.64%ATR (14)26.42Perf 10Y-
Dividend Ex-Date-Quick Ratio4.87Sales Y/Y TTM187.49%Profit Margin33.42%RSI (14)57.61Recom2.25
Dividend Gr. 3/5Y-Current Ratio5.23EPS Q/Q667.31%SMA202.87%Beta0.46Target Price1136.83
Payout0.00%Debt/Eq0.01Sales Q/Q319.90%SMA506.69%Rel Volume1.09Prev Close892.26
Employees1,599LT Debt/Eq0.01EarningsJul 23SMA2008.19%Avg Volume321.58KPrice877.72
IPO DateMay 18, 2017Option/ShortYes / YesEPS/Sales Surpr.-5.90% 66.05%Net Debt/EBITDA-3.25Volume351,717Change-1.63%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-04-26ReiteratedH.C. Wainwright$915 → $940
Jun-01-26ReiteratedWells FargoOverweight$1260 → $1291
May-28-26ReiteratedStifel NicolausBuy$1222 → $1255
May-08-26ReiteratedMorgan StanleyOverweight$1.00 → $1170
May-08-26ReiteratedWells FargoOverweight$1317 → $1260
May-08-26ReiteratedGuggenheimBuy$1160 → $1135
May-07-26ReiteratedStifel NicolausBuy$1.00 → $1222
Feb-26-26ReiteratedStifel NicolausBuy$1248 → $1227
Jan-20-26ReiteratedWells FargoOverweight$542 → $1317
Jan-08-26ReiteratedTruist Financial$950 → $1030
Latest News
Jun-18-26
Jun-18-2603:28PM
Biohaven: Upgrading To Buy On Protein Degraders Pivotal Study InitiationsSeekingAlpha
Jun-11-26
Jun-11-2605:15PM
If You Invested $100 In argenx Stock 5 Years Ago, You Would Have This Much TodayBenzinga
09:41AM
Wedbush Reiterates Outperform on argenx, Maintains $1000 Price TargetBenzinga
09:09AM
Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst SaysBenzinga
Jun-10-26
Jun-10-2601:22AM
argenx SE (ARGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
01:22AM
argenx SE (ARGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue6,2964,1532,190
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,218451227
Gross Profit5,0793,7031,963
Selling, General and Administrative Excl. Other2,2021,3601,055
Research and Development1,9611,364983
Other Operating Expense-314-76-53
Operating Income1,2291,055-22
Interest Expense642
Unusual Expense
———
Non-Operating Income (Expense)-146-228-109
Net Income Before Taxes1,6571,27985
Income Taxes53-13-748
Consolidated Net Income2,3281,292833
Net Income From Continuing Operations1,6311,292833
Net Income2,3281,292833
EPS (Recurring)26.6621.1413.92
EPS (Basic, Before Extraordinaries)26.6621.1413.92
EPS (Diluted)24.7519.6312.78
EBITDA1,3281,311105
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio35.4642.84—
Price To Sales Ratio8.5012.35—
Gross Margin80.6789.1689.63
Operating Margin19.5225.40-1.00
Net Margin36.9831.1138.04
Shares Outstanding616160
Market Capitalization53,54151,298—
Operating Lease Expense
———
Insider Trading Volume
$922.10$827.44$732.78$638.13$543.47● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR